《大行报告》花旗:内地今年维持新能源汽车补贴於现水平 可为新催化剂
花旗发表报告表示,中国乘用车市场讯息联席会(CPCA)公布内地去年12月新能源汽车注册量按年跌15%至13.7万辆,但按月升74%,胜於市场预期;纯电动汽车(BEV,Battery Electric Vehicle)去年12月销量11.9万辆(按年跌8%,按月则升76%)。
花旗指,市场预期内地今年新能源汽车补贴将维持现水平,相信可成新的行业催化剂,该行相信中至高端新能源汽车目前销售,可强於一般大众化新能源汽车。
该行估计,内地去年12月乘用车保费零售销售按年跌5%,料明年1月则按年下滑16.4%,但料奢侈品牌则可维持按年正面增长。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.